Showing 1 - 9 results of 9 for search 'Jin‐Kai Feng', query time: 0.03s
Refine Results
-
1
Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treat... by Hong-Fei Zhu, Jin-Kai Feng, Yan-Jun Xiang, Kang Wang, Li-Ping Zhou, Zong-Han Liu, Yu-Qiang Cheng, Jie Shi, Wei-Xing Guo, Shu-Qun Cheng
Published 2023-06-01
Article -
2
Postoperative adjuvant aspirin for patients with hepatitis B virus-related hepatocellular carcinoma and portal vein tumor thrombus: An open-label, randomized controlled trial by Chong-De Lu, Ya-Bo Jiang, Jin-Kai Feng, Lei Wang, Xu-Biao Wei, Bin Zhou, Xiao-Lu Lin, Wei-Xing Guo, Wan Yee Lau, Shu-Qun Cheng
Published 2023-09-01
Article -
3
Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuation by Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, Yu-Qiang Cheng, Jin-Kai Feng, Zong-Han Liu, Yun-Feng Shan, Yi-Tao Zheng, Qian-Zhi Ni, Shu-Qun Cheng
Published 2023-10-01
Article -
4
Serum metabolomics analysis of biomarkers and metabolic pathways in patients with colorectal cancer associated with spleen-deficiency and qi-stagnation syndrome or damp-heat syndro... by Min Zou, Yan-Sheng Zhang, Jin-Kai Feng, Hao Tu, Ming-Bin Gui, Ya-Nan Wang, Zi-Jie Yang, Zeng-Qiang Yang, Ming Xu, Wei-Qiang Wu, Feng Gao
Published 2023-09-01
Article -
5
A reasonable identification of the early recurrence time based on microvascular invasion for hepatocellular carcinoma after R0 resection: A multicenter retrospective study by Zong‐Han Liu, Zong‐Tao Chai, Jin‐Kai Feng, Yu‐Chao Hou, Xiu‐Ping Zhang, Zhen‐Hua Chen, Yan‐Jun Xiang, Wei‐Xing Guo, Jie Shi, Shu‐Qun Cheng
Published 2023-05-01
Article -
6
Preoperative and Prognostic Prediction of Microvascular Invasion in Hepatocellular Carcinoma: A Review Based on Artificial Intelligence by Yu Jiang Master of Engineering, Kang Wang Master of Medicine, Yu-Ran Wang Master of Engineering, Yan-Jun Xiang Master of Medicine, Zong-Han Liu Doctor of Medicine, Jin-Kai Feng Doctor of Medicine, Shu-Qun Cheng Doctor of Medicine
Published 2023-11-01
Article -
7
Camrelizumab plus gemcitabine and oxaliplatin for the treatment of advanced intrahepatic cholangiocarcinoma: a bi-centric observational retrospective study by Yu-Qing Zhang, Yu-Qing Zhang, Kang Wang, Jin-Kai Feng, Lu-Yun Yuan, Lu-Yun Yuan, Chao Liang, Yan-Jun Xiang, Xu Wang, Xu Wang, Fei-Fei Mao, Shu-Qun Cheng, Shu-Qun Cheng
Published 2023-05-01
Article -
8
Efficacy and safety of TACE combined with lenvatinib and PD‐1 inhibitors for unresectable recurrent HCC: A multicenter, retrospective study by Wei‐Jun Wang, Zong‐Han Liu, Kang Wang, Hong‐Ming Yu, Yu‐Qiang Cheng, Yan‐Jun Xiang, Jin‐Kai Feng, Li‐Ping Zhou, Hong‐Kun Zhou, Wei‐Wei Pan, Wei‐Xing Guo, Jie Shi, Shu‐Qun Cheng
Published 2023-05-01
Article -
9
Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with portal... by Jin-Kai Feng, Zong-Han Liu, Zhi-Gang Fu, Zong-Tao Chai, Ju-Xian Sun, Kang Wang, Yu-Qiang Cheng, Hong-Fei Zhu, Yan-Jun Xiang, Yan-Jun Xiang, Li-Ping Zhou, Jie Shi, Wei-Xing Guo, Jian Zhai, Shu-Qun Cheng
Published 2022-11-01
Article